fingolimod hydrochloride has been researched along with Neuroblastoma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, E; Ekins, S; Foil, DH; Havener, TM; Hickey, AJ; Makarov, V; Monakhova, N; Puhl, AC; Rank, L; Riabova, O; Zorn, KM | 1 |
| Borriello, L; Cherryholmes, G; DeClerck, YA; Lee, H; Li, W; Lifshitz, V; Makovski-Silverstein, A; Priceman, SJ; Yu, H | 1 |
| Ferrer, F; Hla, T; Li, MH | 1 |
| Li, M; Liu, Q; Wood, K; Yang, L; Yang, X; Zhao, P; Zhu, X | 1 |
4 other study(ies) available for fingolimod hydrochloride and Neuroblastoma
| Article | Year |
|---|---|
Multiple approaches to repurposing drugs for neuroblastoma.
Topics: Bayes Theorem; Cell Line, Tumor; Child; Child, Preschool; Crizotinib; Drug Repositioning; Etoposide; Fingolimod Hydrochloride; Humans; Neuroblastoma; Niclosamide | 2022 |
Sphingosine-1-Phosphate Receptor-1 Promotes Environment-Mediated and Acquired Chemoresistance.
Topics: Animals; Apoptosis; Bone Marrow Cells; Drug Resistance, Neoplasm; Etoposide; Fingolimod Hydrochloride; Gene Expression Regulation, Neoplastic; Gene-Environment Interaction; Humans; Mesenchymal Stem Cells; Mice; Neoplasm Recurrence, Local; Neuroblastoma; Receptors, Lysosphingolipid; RNA, Small Interfering; Sphingosine-1-Phosphate Receptors; STAT3 Transcription Factor; Xenograft Model Antitumor Assays | 2017 |
FTY720 inhibits tumor growth and enhances the tumor-suppressive effect of topotecan in neuroblastoma by interfering with the sphingolipid signaling pathway.
Topics: Animals; Cell Death; Child; Child, Preschool; Drug Synergism; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Infant; Male; Mice; Mice, Nude; Neuroblastoma; Phosphotransferases (Alcohol Group Acceptor); Propylene Glycols; Signal Transduction; Sphingolipids; Sphingosine; Topoisomerase I Inhibitors; Topotecan; Xenograft Model Antitumor Assays | 2013 |
Neuroprotective effects of fingolimod in mouse models of Parkinson's disease.
Topics: Animals; Cell Line, Tumor; Fingolimod Hydrochloride; Gene Expression Regulation; Humans; Male; Mice; Neuroblastoma; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Receptors, Lysosphingolipid; Rotenone; Sphingosine-1-Phosphate Receptors | 2017 |